In PBMC‐derived osteoclasts, a set of miRs was found to be differentially expressed in osteoclasts from patients with erosive versus non‐erosive RA or controls, modulating pathways such as mTOR signaling, osteoclast‐immune cell interactions, or fusion and fission processes. Here, MTOR is linked to rheumatoid arthritis.